4.6 Article

Developing CuS for Predicting Aggressiveness and Prognosis in Lung Adenocarcinoma

Journal

GENES
Volume 14, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/genes14051055

Keywords

lung adenocarcinoma; cuproptosis; single cell expression; potential drugs target; prognosis marker

Ask authors/readers for more resources

In this study, the role of cuproptosis in lung adenocarcinoma (LUAD) was evaluated, and a cuproptosis-related score (CuS) was constructed to predict aggressiveness and prognosis in LUAD for precise treatment. CuS had a better predictive performance than cuproptosis genes, possibly due to the synergy of SLC family genes, and patients with high CuS had a poor prognosis. Functional enrichment analysis revealed the correlation between CuS and immune and mitochondrial pathways in multiple datasets. Furthermore, potential drugs targeting high-CuS patients, including AZD3759, a targeted drug for LUAD, were predicted. In conclusion, cuproptosis is involved in LUAD aggressiveness, and CuS can accurately predict the prognosis of patients, providing a basis for precise treatment of patients with high CuS in LUAD.
Cuproptosis is a newfound cell death form that depends on copper (Cu) ionophores to transport Cu into cancer cells. Studies on the relationship have covered most common cancer types and analyzed the links between cuproptosis-related genes (CRGs) and various aspects of tumor characteristics. In this study, we evaluated the role of cuproptosis in lung adenocarcinoma (LUAD) and constructed the cuproptosis-related score (CuS) to predict aggressiveness and prognosis in LUAD, so as to achieve precise treatment for patients. CuS had a better predictive performance than cuproptosis genes, possibly due to the synergy of SLC family genes, and patients with a high CuS had a poor prognosis. Functional enrichment analysis revealed the correlation between CuS and immune and mitochondrial pathways in multiple datasets. Furthermore, we predicted six potential drugs targeting high-CuS patients, including AZD3759, which is a targeted drug for LUAD. In conclusion, cuproptosis is involved in LUAD aggressiveness, and CuS can accurately predict the prognosis of patients. These findings provide a basis for precise treatment of patients with high CuS in LUAD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available